Stay updated on Nivolumab for IDH Mutant Gliomas Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for IDH Mutant Gliomas Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a nivolumab study in recurrent or progressive IDH-mutant gliomas is available, with detailed study information and posted results.
    Difference
    51%
    Check dated 2026-11-07T13:00:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:53:35.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T14:33:42.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T14:22:18.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer revision identifier updates from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:23:10.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the previous detailed study content with an access-restricted view. This reflects an access issue rather than a modification to the study data.
    Difference
    18%
    Check dated 2026-09-19T20:33:33.000Z thumbnail image

Stay in the know with updates to Nivolumab for IDH Mutant Gliomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for IDH Mutant Gliomas Clinical Trial page.